Sort
130,381 grants matching “hiv”
HIV-1 and host interactions at molecular level
$1,400,080Maureen Goodenow · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
ARV effects on HIV epidemiology &behaviors Rakai Uganda
$1,400,001Columbia University Health Sciences · R01 · FY2005 · HD
HIV TREATMENT FOR RESEARCH SUBJECTS OR BY RESEARCHERS IN KENYA
$1,400,000Sumathi Sivapalasingam · New York University School Of Medicine · U62 · FY2008 · PS
Economic Modeling for HIV, Viral Hepatitis, STD, TB and School Health
$1,400,000Joshua A Salomon · Harvard School Of Public Health · U38 · FY2014 · PS
INCREASING ACCESS TO AND UPTAKE OF HIV PREVENTION, CONFIDENTIAL VOLUNTARY COUNSEL
$1,400,000Harintsoa Lalah Rambeloson · Population Services International · U2G · FY2010 · PS
HIV Research for Prevention Conference, HIVR4P 2020
$1,400,000Chris Beyrer · Ias · R13 · FY2020 · AI
HIV Research for Prevention 2018: Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P)
$1,400,000Georgia D Tomaras · Duke University · R13 · FY2018 · AI
Small Molecular Inactivators of HIV
$1,400,000Daniel H Appella · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
IMPLEMENTATION OF MULTI-DISCIPLINARY HIV CARE FOR SEXUALLY ABUSED CHILDREN
$1,400,000Elwyn Nachany Chomba · University Teaching Hospital · U62 · FY2007 · PS
GH14-1403, S. Africa: Strengthening the Evidence Base and Capacity for Implementing HIV Prevention
$1,400,000King Holmes · University Of Washington · U2G · FY2016 · GH
HIVR4P 2023, the 5th HIV Research for Prevention Conference, Lima, Peru, and virtually, 22-26 October 2023
$1,400,000Chris Beyrer · Ias · R13 · FY2023 · AI
TECHNICAL ASSISTANCE IN SUPPORT OF HIV PREVENTION, CARE AND TREATMENT PROGRAMS
$1,400,000Ronald Magarick · Johns Hopkins University · U2G · FY2012 · PS
RAPID SCALE UP FOR HIV CARE AND TREATMENT SERVICES IN NORTHEASTERN
$1,400,000Ahoua Kone · Health Alliance International · U2G · FY2012 · PS
HIV PREVENTION TRIAL UNIT (HPTU)
$1,399,999University Of North Carolina Chapel Hill · U01 · FY2000 · AI
A Cluster RCT to Increase HIV Testing in Substance Use Treatment Programs
$1,399,895Lisa R Metsch · Columbia University Health Sciences · R01 · FY2019 · DA
In vivo HSC gene therapy using a multi-modular HDAd vector for HIV cure
$1,399,750Andre Michael Lieber · University Of Washington · R01 · FY2025 · AI
Progress Report for Neurotherapeutics Unit
$1,399,684Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIC · FY2023 · NS
Molecular Analysis of Tuberculosis Immunity
$1,399,546William Robert Jacobs · Albert Einstein College Of Medicine · P01 · FY2006 · AI
Cytokines in AIDS and Cancer Immunotherapy
$1,399,536George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
UPR/MDACC: Partnership for Excellence in Cancer Research (2 of 2)
$1,399,411Brad R Weiner · University Of Puerto Rico Med Sciences · U54 · FY2021 · CA
Molecularly targeted natural products discovery from diverse natural sources
$1,398,921Kirk Gustafson · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Role of reservoir composition and T cell immunity in HIV rebound kinetics
$1,398,678Dennis J Hartigan-O'Connor · University Of California At Davis · P01 · FY2019 · AI
Clinical Trials of Patients with AIDS-Related Malignancies
$1,398,422Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
NeMO Archive: SCORCH Support, Coordination and Outreach
$1,398,182Owen R White · University Of Maryland Baltimore · UM1 · FY2020 · DA
Production of Research Cell Banks
$1,397,939Jon Carl Mirsalis · Advanced Bioscience Laboratories, Inc. · N01 · FY2013 · AI